InvestSMART

IperionX Limited (ASX: IPX) - Announcements

Current share price for IPX : $3.440 0.04 (1.18%)+

ASX company news and announcements for IperionX Limited (IPX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All IperionX Limited (IPX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than IperionX Limited (IPX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for IperionX Limited (IPX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$1,246 June 2022 Quarterly Report 29 Jul 2022 11:28AM $0.700 $3.440 risen by 391.43%
$1,246 IperionX and Oak Ridge National Laboratory Collaboration 25 Jul 2022 9:10AM $0.720 $3.440 risen by 377.78%
$1,246 Becoming a substantial holder 8 Jul 2022 8:19AM $0.670 $3.440 risen by 413.43%
$1,246 Company Presentation - Scoping Study Update 7 Jul 2022 9:30AM $0.720 $3.440 risen by 377.78%
$1,246 IperionX Titan Project Scoping Study 30 Jun 2022 8:27AM $0.810 $3.440 risen by 324.69%
$1,246 Company Presentation - Nasdaq Listing 20 Jun 2022 8:57AM $0.795 $3.440 risen by 332.70%
$1,246 IperionX to Commence Trading on Nasdaq 16 Jun 2022 8:58AM $0.680 $3.440 risen by 405.88%
$1,246 Iperionx and UTIA Sustainability Research Project 25 May 2022 9:16AM $0.840 $3.440 risen by 309.52%
$1,246 Change of Director's Interest Notice 5 May 2022 9:33AM $1.025 $3.440 risen by 235.61%
$1,246 Notice under Section 708A 28 Apr 2022 11:49AM $1.100 $3.440 risen by 212.73%
$1,246 Application for quotation of securities - IPX 28 Apr 2022 11:47AM $1.100 $3.440 risen by 212.73%
$1,246 March 2022 Quarterly Report 28 Apr 2022 8:48AM $1.070 $3.440 risen by 221.50%
$1,246 Notice under Section 708A 6 Apr 2022 5:03PM $1.325 $3.440 risen by 159.62%
$1,246 Application for quotation of securities - IPX 6 Apr 2022 5:00PM $1.325 $3.440 risen by 159.62%
$1,246 Notification regarding unquoted securities - IPX 6 Apr 2022 4:54PM $1.325 $3.440 risen by 159.62%
$1,246 Draft U.S. Registration Statement (Form 20-F) 30 Mar 2022 9:50AM $1.235 $3.440 risen by 178.54%
$1,246 IperionX Files Registration Statement for U.S. Listing 30 Mar 2022 9:28AM $1.235 $3.440 risen by 178.54%
$1,246 ThinkEquity Presentation 28 Mar 2022 9:42AM $1.265 $3.440 risen by 171.94%
$1,246 IperionX Scales Titanium Metal Production 22 Mar 2022 9:32AM $1.100 $3.440 risen by 212.73%
$1,246 Jefferies Aerospace & Defense Group Presentation 17 Mar 2022 9:46AM $0.925 $3.440 risen by 271.89%
$1,246 Half Year Accounts 15 Mar 2022 6:11PM $0.910 $3.440 risen by 278.02%
$1,246 IperionX & Energy Fuels Progress Rare Earth Collaboration 8 Mar 2022 9:25AM $0.980 $3.440 risen by 251.02%
$1,246 IperionX & MRL to Qualify U.S. Titanium Powder for U.S. Navy 2 Mar 2022 9:38AM $0.865 $3.440 risen by 297.69%
$1,246 Suspension from Official Quotation - cob 7 Sept 2011 1 Sep 2011 12:39PM $0.290 $3.440 risen by 1,086.21%
$1,246 TPM: IntraPower takeover offer closed 30 Aug 2011 4:24PM $0.290 $3.440 risen by 1,086.21%

401 - 425 of 464 results

Page 17 of 19

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.